These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11021597)

  • 21. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.
    Kreppel F; Luther TT; Semkova I; Schraermeyer U; Kochanek S
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1965-70. PubMed ID: 12037006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 expression by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant SOD1 transgenic mice.
    Yamashita S; Mita S; Arima T; Maeda Y; Kimura E; Nishida Y; Murakami T; Okado H; Uchino M
    Gene Ther; 2001 Jul; 8(13):977-86. PubMed ID: 11438832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient transduction of murine B lymphocytes and B lymphoma lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins.
    Li L; Wickham TJ; Keegan AD
    Gene Ther; 2001 Jun; 8(12):938-45. PubMed ID: 11426334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.
    Ghadge GD; Roos RP; Kang UJ; Wollmann R; Fishman PS; Kalynych AM; Barr E; Leiden JM
    Gene Ther; 1995 Mar; 2(2):132-7. PubMed ID: 7536617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.
    Davidson BL; Allen ED; Kozarsky KF; Wilson JM; Roessler BJ
    Nat Genet; 1993 Mar; 3(3):219-23. PubMed ID: 8387378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
    Kügler S; Kilic E; Bähr M
    Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
    Rittner K; Schreiber V; Erbs P; Lusky M
    Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
    Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
    Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage.
    Federici T; Liu JK; Teng Q; Yang J; Boulis NM
    Neurosurgery; 2007 May; 60(5):911-8; discussion 911-8. PubMed ID: 17460527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.
    Reynolds PN; Zinn KR; Gavrilyuk VD; Balyasnikova IV; Rogers BE; Buchsbaum DJ; Wang MH; Miletich DJ; Grizzle WE; Douglas JT; Danilov SM; Curiel DT
    Mol Ther; 2000 Dec; 2(6):562-78. PubMed ID: 11124057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization does not interfere with uptake and transport by motor neurons of the binding fragment of tetanus toxin.
    Fishman PS; Matthews CC; Parks DA; Box M; Fairweather NF
    J Neurosci Res; 2006 Jun; 83(8):1540-3. PubMed ID: 16557581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons.
    Carlton E; Teng Q; Federici T; Yang J; Riley J; Boulis NM
    Neurosurgery; 2008 Dec; 63(6):1175-82; discussion 1182-4. PubMed ID: 19057331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective repeat administration with adenovirus vectors to the muscle.
    Chen P; Kovesdi I; Bruder JT
    Gene Ther; 2000 Apr; 7(7):587-95. PubMed ID: 10819574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.